Elizabeth M. Wulff-Burchfield, MD
Dr. Wulff-Burchfield is an assistant professor of medicine in the divisions of medical oncology and palliative medicine at the University of Kansas Health System in Kansas City, Kansas.
Dr. Wulff-Burchfield attended Duke University School of Medicine and earned her Doctorate of Medicine in 2010. Dr. Wulff-Burchfield then completed her internship and residency in internal medicine and her fellowships in medical oncology and hospice and palliative medicine at Vanderbilt University Medical Center in Nashville, TN. Following completion of her training, she joined the faculty at the University of Kansas, where her areas of specialization are in genitourinary medical oncology and outpatient palliative medicine for patients with cancer.
Dr. Wulff-Burchfield has separate oncology and palliative care practices. In her oncology practice, she treats bladder, kidney, prostate, and testicular cancer using the most innovative therapies and technologies, including clinical trials. She collaborates closely with colleagues in urologic oncology and radiation oncology in order to create a data-driven and patient-centered treatment plan.
In her palliative care practice, she treats patients with any cancer diagnosis, helping support them and promote a good quality of life while they are going through cancer treatment.
Education and Training
- BA, Biology, St. Olaf College, Northfield, Mn
- Duke University School of Medicine, Durham, Nc
Licensure, Accreditations & Certifications
- American Board Of Internal Medicine
- American Board of Internal Medicine Hospice and Palliative
- Kansas State Board of Healing Arts
- KU COVID-19 Clinical Research Task Force, Task Force, Chair, 2020 - Present
- American Association of Hospice and Palliative Medicine, Member, 2018 - Present
Dr. Wulff-Burchfield's overarching research interest is in quality of life and supportive care for patients undergoing treatment for bladder, kidney, and prostate cancer.
She is the principal investigator of studies investigating novel methods for symptom assessment and communication for patients receiving oral therapies for renal cell carcinoma, chemotherapy-induced taste changes in patients with muscle-invasive bladder cancer, geriatric assessment for patients with muscle-invasive bladder cancer, and has completed research regarding preoperative urostomy education for patients undergoing radical cystectomy for bladder cancer. She is also leading an externally-funded oncology clinician educational series and quality improvement study about patient assessment, symptom assessment, and supportive care in renal cell carcinoma via the University of Kansas and Masonic Cancer Alliance Project ECHO® platform.
In addition to her own research, she is on the genitourinary and QOL/symptom control research committees in two oncology cooperative groups and is on the National Cancer Institute Symptom Management and Quality of Life Committee, where she helps guide the research across the United States that is seeking to improve quality of life and symptom control for persons diagnosed with cancer.